Galderma Group AG/ADR
SEC registrant with listed symbol(s): GALDY (OTC), GDERF (OTC). This is a filing-identity record, not a verified operating-company profile.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
Company positioning and business
SEC registrant with listed symbol(s): GALDY (OTC), GDERF (OTC). This is a filing-identity record, not a verified operating-company profile. [2]
The SEC classifies Galderma Group AG/ADR under (SIC ). Its reported business address is 383 MADISON AVENUE, FLOOR 11, NEW YORK, NY, 10179. Industry classification does not establish its full product range. [1]
Financial year, securities and disclosures
The SEC submissions record gives Galderma Group AG/ADR a fiscal year end of 1231 (MMDD). Individual filings below identify their own reporting period; the filing date is the publication event, not the financial year end. [1]
Listed securities: GALDY (OTC), GDERF (OTC). Multiple symbols may represent different share classes or securities of the same registrant. [2]
Financial results and regulatory disclosures
No individual financial documents have been indexed yet. Open the source to consult company disclosures. [2]
Source-verified relationships
Related entities and concepts
Frequently asked questions
Which industry classification does the SEC report for Galderma Group AG/ADR?
The submissions record lists , SIC . [1]
Where can the financial reports of Galderma Group AG/ADR be read?
The financial disclosures section links to collected annual, quarterly and current reports. The SEC source provides the broader filing record. [2]
Galderma Group AG/ADR relationship map
Select a node to inspect its relationship and source.
1 verified direct relationships. Industry peers are not relationship edges.
Sources and review dates
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.